ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 174 filers reported holding ESPERION THERAPEUTICS INC NE in Q4 2019. The put-call ratio across all filers is 0.88 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $8,767,000 | +408.2% | 235,855 | +601.6% | 0.95% | +170.9% |
| Q2 2020 | $1,725,000 | -36.5% | 33,615 | -61.0% | 0.35% | -33.8% |
| Q1 2020 | $2,715,000 | -33.6% | 86,118 | +25.6% | 0.53% | +25.7% |
| Q4 2019 | $4,089,000 | +964.8% | 68,570 | +720.9% | 0.42% | +926.8% |
| Q4 2018 | $384,000 | -88.3% | 8,353 | -88.7% | 0.04% | -84.5% |
| Q3 2018 | $3,287,000 | +11.8% | 74,071 | -1.3% | 0.26% | +27.5% |
| Q2 2018 | $2,940,000 | -40.9% | 75,020 | +9.1% | 0.21% | -41.9% |
| Q1 2018 | $4,973,000 | +0.3% | 68,748 | +13.4% | 0.36% | +12.3% |
| Q2 2015 | $4,957,000 | -26.6% | 60,630 | -16.8% | 0.32% | -24.9% |
| Q1 2015 | $6,751,000 | +316.2% | 72,909 | +81.8% | 0.42% | +317.8% |
| Q4 2014 | $1,622,000 | +175.4% | 40,104 | +66.6% | 0.10% | +173.0% |
| Q3 2014 | $589,000 | – | 24,070 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 4,468,835 | $27,840,842 | 18.82% |
| Ikarian Capital, LLC | 1,891,147 | $11,781,846 | 2.84% |
| Altium Capital Management LP | 620,000 | $3,862,600 | 1.96% |
| Ikarian Capital, LLC | 1,296,900 | $8,079,687 | 1.95% |
| Parkman Healthcare Partners LLC | 822,784 | $5,125,944 | 1.36% |
| Deep Track Capital, LP | 4,000,000 | $24,920,000 | 1.05% |
| Monaco Asset Management SAM | 470,100 | $2,928,723 | 0.88% |
| BRAIDWELL LP | 3,393,405 | $21,140,913 | 0.71% |
| Telemetry Investments, L.L.C. | 71,000 | $442 | 0.70% |
| Rhenman & Partners Asset Management AB | 900,000 | $5,607,000 | 0.58% |